changing from tirzepatide to retatrutide Retatrutide: The "Triple G" Peptide That Could Rival Bariatric Surgery (And Why You Shouldn't Wait) Switching from tirzepatide to retatrutide:

GLP-1 RAs have also shown efficacy in metabolic dysfunction-associated steatotic liver disease (MASLD) and are now recommended as a first-line antidiabetic treatment for patients with metabolic dysfunction-associated steatohepatitis (MASH) and diabetes [82]

Once in solution, it is highly sensitive to temperature and should be stored at $4$C for immediate use or aliquoted and frozen to prevent degradation from multiple freeze-thaw cycles.Strictly for Research and Laboratory UseAll products, including Retatrutide 5mg, 12mg, 15mg, 24mg, and 35mg, are intended STRICTLY for research and laboratory use only

There are a few reasons why patients on GLP-1 RAs might develop nutritional deficiencies: Reduced Food Intake: As noted, these medications greatly reduce how much you eat

Ahren B, Pacini G, Foley JE, Schweizer A

I don't see that as safe because these medications haven't been tested in a population that's that young. This applies to both breastfeeding and pumping breast milk thats fed to a baby, she adds